Bridgewater Associates LP Has $4.91 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Bridgewater Associates LP cut its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 40.0% during the third quarter, HoldingsChannel reports. The fund owned 181,352 shares of the medical instruments supplier’s stock after selling 120,669 shares during the quarter. Bridgewater Associates LP’s holdings in DENTSPLY SIRONA were worth $4,907,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Tidal Investments LLC increased its position in DENTSPLY SIRONA by 292.4% in the 1st quarter. Tidal Investments LLC now owns 24,149 shares of the medical instruments supplier’s stock worth $802,000 after purchasing an additional 17,995 shares during the last quarter. Comerica Bank raised its position in DENTSPLY SIRONA by 2.9% during the first quarter. Comerica Bank now owns 42,568 shares of the medical instruments supplier’s stock valued at $1,413,000 after acquiring an additional 1,205 shares in the last quarter. Cetera Advisors LLC lifted its stake in DENTSPLY SIRONA by 18.6% in the first quarter. Cetera Advisors LLC now owns 17,052 shares of the medical instruments supplier’s stock valued at $566,000 after acquiring an additional 2,675 shares during the last quarter. Teachers Retirement System of The State of Kentucky grew its position in DENTSPLY SIRONA by 6.2% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 19,370 shares of the medical instruments supplier’s stock worth $642,000 after acquiring an additional 1,130 shares in the last quarter. Finally, OLD National Bancorp IN increased its stake in shares of DENTSPLY SIRONA by 84.2% during the 2nd quarter. OLD National Bancorp IN now owns 13,560 shares of the medical instruments supplier’s stock worth $338,000 after purchasing an additional 6,198 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Robert W. Baird reduced their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Evercore ISI lowered their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Tuesday, November 19th. Finally, Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Seven research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $19.65 on Friday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The business has a 50 day moving average price of $22.55 and a 200 day moving average price of $24.79. The company has a market cap of $3.91 billion, a price-to-earnings ratio of -9.49, a PEG ratio of 1.93 and a beta of 1.02. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. During the same quarter in the prior year, the business earned $0.49 earnings per share. The firm’s revenue for the quarter was up .4% on a year-over-year basis. Research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.